Showing 606 news articles about New & experimental HIV treatments

Filters Content type: News Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

People with limited treatment options

ICAAC: Raltegravir shows sustained effect in highly treatment-experienced patients

News
19 September 2007
Starting treatment

ICAAC: Boosted darunavir non-inferior to boosted lopinavir after 48 weeks in treatment-naïve

News
19 September 2007
New & experimental HIV treatments

Apricitabine strong in phase 2 study, 24-week data released

News
5 September 2007
New & experimental HIV treatments

First fixed dose combination for children approved for PEPFAR use

News
15 August 2007
New & experimental HIV treatments

Maraviroc receives accelerated approval in US

News
7 August 2007
Starting treatment

IAS: Maraviroc slightly less effective but more tolerable in treatment-naive patients

News
25 July 2007
New & experimental HIV treatments

IAS: Vicriviroc still effective at 48 weeks in treatment-experienced, but relationship with cancer remains uncertain

News
24 July 2007
Starting treatment

IAS: Integrase inhibitor raltegravir (MK-0518) potent, durable and more tolerable than efavirenz in treatment-naive at 48 weeks

News
24 July 2007
New & experimental HIV treatments

IAS: Novel once-daily CCR5 antagonist, INC9471, appears potent, well tolerated after 14 days monotherapy

News
24 July 2007
New & experimental HIV treatments

Kaletra tablet for children coming soon, says Abbott

News
22 July 2007
Access to healthcare

IAS: Hope and excitement as conference officially opens

News
22 July 2007
New & experimental HIV treatments

Maraviroc gets scientific thumbs up from European drugs body

News
20 July 2007
New & experimental HIV treatments

Pfizer advises maraviroc dose increase if combined with etravirine

News
20 July 2007
Resistance

Darunavir superior to lopinavir in 48-week study in treatment-experienced patients

News
6 July 2007
People with limited treatment options

TMC-125 and darunavir show strong effect in highly treatment-experienced, even without T-20

News
6 July 2007
New & experimental HIV treatments

Brazil: Kaletra price cut agreed as generic efavirenz arrives

News
5 July 2007
People with limited treatment options

Merck hopes for US integrase inhibitor license by October

News
28 June 2007
New & experimental HIV treatments

Oral solution of bevirimat provides encouraging results, maturation inhibitor moves ahead

News
25 June 2007
New & experimental HIV treatments

Maraviroc approval delayed in the US

News
21 June 2007
New & experimental HIV treatments

Treating PML: hopes for future focus on mastering immune response

News
11 May 2007
New & experimental HIV treatments

Clinton Foundation announces new price cuts for tenofovir and second-line drugs

News
8 May 2007
New & experimental HIV treatments

Substantial HIV reduction persists for 2-3 weeks with single dose of PRO-140 antibody

News
1 May 2007
New & experimental HIV treatments

Tenofovir and Truvada licensed in South Africa

News
26 April 2007
New & experimental HIV treatments

Abbott offers Aluvia to Thailand in return for compulsory licensing halt

News
25 April 2007